Intrinsic Therapeutics raises $28 mln
Intrinsic Therapeutics Inc said May 10 it raised a $28 million equity round co-led by New Enterprise and Delos Capital, along with a $21 million debt facility with CRG. Other investors include Greenspring Associates, Quadrille Capital and a corporate strategic. Intrinsic, of Boston, is a medical device company.
11 May 2017•4 mins read
